Astute_Analytica_Logo (PNG) (3).png
Global Clinical Trial Support Service Market to Hit Valuation of USD 47.1 Billion By 2032 | Asia Pacific and Latin America Are Booming in Clinical Trial Support Services Says Astute Analytica
March 06, 2024 09:30 ET | AstuteAnalytica India Pvt. Ltd.
New Delhi, March 06, 2024 (GLOBE NEWSWIRE) -- The global clinical trial support service market was valued at US$ 25.2 billion in 2023 and is expected to reach US$ 47.1 billion by 2032, growing at a...
AB Science annonce q
AB Science annonce que Santé Canada a émis un Avis de Non-Conformité-Retrait (ANC-R) pour le masitinib dans la SLA
February 26, 2024 12:32 ET | AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE QUE SANTÉ CANADA A ÉMIS UN AVIS DE NON-CONFORMITÉ-RETRAIT (ANC-R) POUR LE MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE AB SCIENCE A L'INTENTION DE...
AB Science announces
AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALS
February 26, 2024 12:32 ET | AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS ISSUED A NOTICE OF NON-COMPLIANCE-WITHDRAWAL (NON/w) FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AB SCIENCE INTENDS TO SUBMIT A REQUEST...
Ocular Logo.png
Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
February 22, 2024 07:30 ET | Ocular Therapeutix, Inc.
Industry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair Jeffrey S. Heier, MD to become Chief Scientific Officer, Peter K. Kaiser, MD to be Medical Director, and Sanjay...
FINAL_VeruIncLogo_RGB_300dpi.jpg
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
February 20, 2024 08:30 ET | Veru Inc.
MIAMI, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality...
HelixBind_Logo_AS2-no BG (2018).png
Study Demonstrates the Potential of HelixBind’s RaPID/BSI Assay to Accurately Identify Bloodstream Infections Associated with Sepsis in Patients Undergoing Antimicrobial Treatment
February 12, 2024 08:30 ET | HelixBind
Study shows RaPID/BSI assay can accurately identify bloodstream infections associated with sepsis in patients undergoing antimicrobial treatment.
Full Logo - OKYO .jpg
OKYO Pharma Receives FDA Approval of IND for OK-101 in Neuropathic Corneal Pain
February 09, 2024 07:00 ET | OKYO Pharma LTD
OK-101 is the first IND clearance granted by FDA for a drug to begin clinical studies specifically to treat patients suffering with neuropathic corneal pain (NCP), a major unmet medical needThe...
LEXEO logo .png
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
February 05, 2024 07:00 ET | Lexeo Therapeutics
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
MASH PIs - Velocity (1)
Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions
October 25, 2023 07:04 ET | Velocity Clinical Research, Inc.
• Add two KOLs: Dr Kris Kowdley and Dr Nadege Gunn • Builds on existing MASH/MASLD capabilities at 23 sites globally DURHAM N.C., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical...
FINAL lOGO.png
Immune Checkpoint Inhibitors Lead the Bladder Cancer Treatment Drugs Market with US$ 14.8 Billion in Revenue by 2033: Persistence Market Research
March 28, 2023 09:35 ET | Persistence Market Research
New York, March 28, 2023 (GLOBE NEWSWIRE) -- As per this new industry analysis by Persistence Market Research, the global Bladder Cancer Treatment Drugs Market was valued at US$ 3.04 billion in 2022...